dabigatran
Generic: dabigatran etexilate
Labeler: novadoz pharmaceuticals llcDrug Facts
Product Profile
Brand Name
dabigatran
Generic Name
dabigatran etexilate
Labeler
novadoz pharmaceuticals llc
Dosage Form
CAPSULE
Routes
Active Ingredients
dabigatran etexilate mesylate 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72205-204
Product ID
72205-204_50fb8204-a087-4f97-ab57-85773b8c0065
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213879
Listing Expiration
2027-12-31
Marketing Start
2024-05-22
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72205204
Hyphenated Format
72205-204
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dabigatran (source: ndc)
Generic Name
dabigatran etexilate (source: ndc)
Application Number
ANDA213879 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 6 BLISTER PACK in 1 CARTON (72205-204-34) / 10 CAPSULE in 1 BLISTER PACK
- 60 CAPSULE in 1 BOTTLE (72205-204-60)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "50fb8204-a087-4f97-ab57-85773b8c0065", "openfda": {"upc": ["0372205203600", "0372205204607"], "unii": ["SC7NUW5IIT"], "rxcui": ["1037045", "1037179", "1723476"], "spl_set_id": ["6f79088b-b353-485a-9df4-6f5088f5bd0f"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (72205-204-34) / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "72205-204-34", "marketing_start_date": "20241001"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (72205-204-60)", "package_ndc": "72205-204-60", "marketing_start_date": "20240524"}], "brand_name": "DABIGATRAN", "product_id": "72205-204_50fb8204-a087-4f97-ab57-85773b8c0065", "dosage_form": "CAPSULE", "pharm_class": ["Direct Thrombin Inhibitor [EPC]", "Thrombin Inhibitors [MoA]"], "product_ndc": "72205-204", "generic_name": "DABIGATRAN ETEXILATE", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DABIGATRAN", "active_ingredients": [{"name": "DABIGATRAN ETEXILATE MESYLATE", "strength": "150 mg/1"}], "application_number": "ANDA213879", "marketing_category": "ANDA", "marketing_start_date": "20240522", "listing_expiration_date": "20271231"}